References
- Lam C. Heart failure in Southeast Asia: facts and numbers. ESC Heart Fail. 2015;2:46–49.
- Lam CSP, Teng T-H, Tay WT, et al. Regional and ethnic differences among patients with heart failure in Asia: the Asian sudden cardiac death in heart failure registry. Eur Heart J. 2016;37:3141–3153.
- Califano S, Pagani FD, Malani PN. Left ventricular assist device-associated infections. Infect Dis Clin North Am. 2012;26:77–87.
- Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001;345:1435–1443.
- Lim CP, Sivathasan C, Tan TE, et al. Use of left ventricular assist device (HeartMate II): a Singapore experience. Artif Organs. 2014;38:543–548.
- Kimura M, Kinoshita O, Nawata K, et al. Midterm outcome of implantable left ventricular assist devices as a bridge to transplantation: Single-center experience in Japan. J Cardiol. 2015;65:383–389.
- Nienaber JJC, Kusne S, Riaz T, et al. Clinical manifestations and management of left ventricular assist device-associated infections. Clin Infect Dis. 2013;57:1438–1448.
- Pereda D, Conte JV. Left ventricular assist device driveline infections. Cardiol Clin. 2011;29:515–527.
- Hannan MM, Husain S, Mattner F, et al. Working formulation for the standardization of definitions of infections in patients using ventricular assist devices. J Heart Lung Transplant. 2011;30:375–384.
- Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30:633–638.
- CDC N. CDC/NHSN surveillance definitions for specific types of infections. Surveill Defin. 2014;2015:(January):1–24.
- O’Horo JC, Abu Saleh OM, Stulak JM, et al. Left ventricular assist device infections: a systematic review. ASAIO J. 2017;1–8.
- Siméon S, Flécher E, Revest M, et al. Left ventricular assist device-related infections: a multicentric study. Clin Microbiol Infect. 2017;10–13.
- Rogers JG, Pagani FD, Tatooles AJ, et al. Intrapericardial left ventricular assist device for advanced heart failure. N Engl J Med. 2017;376:451–460.
- Miller LW, Pagani FD, Russell SD, et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med. 2007;357:885–896.
- Obbard JP, Fang LS. Airborne concentrations of bacteria in a hospital environment in Singapore. Water Air Soil Pollut. 2003;144:333–341.
- Zierer A, Melby SJ, Voeller RK, et al. Late-onset driveline infections: the Achilles' heel of prolonged left ventricular assist device support. Ann Thorac Surg. 2007;84:515–520.
- Sivaratnam K, Duggan JM. Left ventricular assist device infections: three case reports and a review of the literature. ASAIO J. 2002;48:2–7.
- Sinha P, Chen JM, Flannery M, et al. Infections during left ventricular assist device support do not affect posttransplant outcomes. Circulation. 2000;102:III194–III199.
- Gordon RJ, Quagliarello B, Lowy FD. Ventricular assist device-related infections. Lancet Infect Dis. 2006;6:426–437.
- Simon D, Fischer S, Grossman A, et al. Left ventricular assist device-related infection: treatment and outcome. Clin Infect Dis. 2005;40:1108–1115.
- Deng MC, Loebe M, El-Banayosy A, et al. Mechanical circulatory support for advanced heart failure: effect of patient selection on outcome. Circulation. 2001;103:231–237.
- Maniar S, Kondareddy S, Topkara VK. Left ventricular assist device-related infections: past, present and future. Expert Rev Med Devices. 2011;8:627–634.
- Poston RS, Husain S, Sorce D, et al. LVAD bloodstream infections: therapeutic rationale for transplantation after LVAD infection. J Hear Lung Transplant. 2003;22:914–921.
- Goldstein DJ, Naftel D, Holman W, et al. Continuous-flow devices and percutaneous site infections: clinical outcomes. J Heart Lung Transplant. 2012;31:1151–1157.
- Malani PN, Dyke DBS, Pagani FD, et al. Nosocomial infections in left ventricular assist device recipients. Clin Infect Dis. 2002;34:1295–1300.
- Holman WL, Park SJ, Long JW, et al. Infection in permanent circulatory support: experience from the REMATCH trial. J Heart Lung Transplant. 2004;23:1359–1365.
- Gordon RJ, Weinberg AD, Pagani FD, et al. Prospective, multicenter study of ventricular assist device infections. Circulation. 2013;127:691–702.
- Herrmann M, Weyand M, Greshake B, et al. Left ventricular assist device infection is associated with increased mortality but is not a contraindication to transplantation. Circulation. 1997;95:814–817.